Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

Glycemic Index Laboratories, Inc20 enrolled

Overview

To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Blood Glucose, Postprandial

Interventions

PolyGlycopleX (PGX)DIETARY_SUPPLEMENT

2.5 grams of PGX

PolyGlycopleX (PG)DIETARY_SUPPLEMENT

5.0 grams of PGX

PolyGlycopleXDIETARY_SUPPLEMENT

7.5 grams of PGX

Control

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy individuals * 18-75 years old * BMI less than 35 kg/m2 Exclusion Criteria: * Medications influencing gastrointestinal function * Pregnancy

Locations (1)

Glycemic Index Laboratories, Inc.

Toronto, Ontario, Canada

Outcomes

Primary Outcomes

postprandial glycemia

Time frame: Acute study measuring postprandial glucose levels over 2 hours

Secondary Outcomes

The glucose reduction index potential (GRIP). The GRIP factor is the reduction in glycemic index units per gram of fiber.

Time frame: Data analysis

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.